Clinical trials
Genetics clinical trials
Below are recruiting genetics clinical trials, each written for real people, not researchers. We’re tracking 704 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06844851Recruiting
Genetic causes of cardiac arrest in young adults
This study looks at the genetic causes of cardiac arrest that happens outside the hospital in younger people. If you or a family member had a cardiac arrest before age 50 in Lombardy, Italy, researchers may test your DNA to find inherited risks that could affect other family members.
Pavia, PaviaAges 18–50 - NCT06847256Recruiting
Genetic risk for heat stroke study
This study looks for a possible genetic link to heat stroke. Researchers will compare heat responses in people who carry the cystic fibrosis gene against those who do not.
Iowa City, IowaAges 18–60 - NCT06850311RecruitingPhase 2/Phase 3
Herbal ointment for mild to severe eczema
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
New Taipei CityAges 18–65 - NCT06862063Recruiting
Genetic study of spontaneous neck artery tears
This study looks at the genes of people who have had a spontaneous tear in a neck artery. It aims to find if there is an underlying genetic cause, which could help guide treatment for you and your family.
Rome, LazioAges 18 years+ - NCT06875700Recruiting
Genetic testing study for sarcoma patients and relatives
This study looks at how people think about and respond to genetic testing for a specific genetic change found in sarcoma (a type of cancer). It aims to understand beliefs and attitudes toward this testing.
Salt Lake City, UtahAges 18 years+ - NCT06886425Recruiting
Study of how azacytidine works in blood cancers
This study looks at how certain enzymes in your body affect the way a drug called azacytidine works against blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The goal is to better understand who might benefit most from this treatment.
MarseilleAges 18 years+ - NCT06886672Recruiting
Genetic study in pleural mesothelioma
This study looks at the role of inherited genes in malignant pleural mesothelioma. It includes people recently diagnosed and healthy people who were exposed to asbestos. The goal is to better understand why some people get this cancer.
Pavia, PaviaAges 18 years+ - NCT06889662Recruiting
Genetic testing study for arrhythmic myocarditis
This study tests whether looking at your genes can help doctors understand and treat arrhythmic myocarditis (a type of heart muscle inflammation that can cause irregular heartbeats). It may help find better treatments for people with this condition.
Milan, Italy/MilanAges 10–80 - NCT06892964Recruiting
Italian registry and biobank for ML patients
This study creates a national registry and biobank to collect medical information and biological samples from people with any type of ML, helping research into the condition.
RomaAges Up to 100 years - NCT06894823Recruiting
Precision oncology platform for patients in central-southern Italy
This trial creates a program to offer personalized cancer care for patients living in central-southern Italy. It aims to use your tumor's genetic information to find the best treatment.
NaplesAges Any age - NCT06896266Recruiting
Genetic study of arrhythmia-induced heart muscle weakness
This study looks at the genes of people whose heart muscle becomes weak due to a fast or irregular heartbeat (atrial fibrillation or flutter). The goal is to better understand why this happens in some people and not others.
Ciudad Real, Castille-La ManchaAges 18 years+ - NCT06906562RecruitingPhase 2
Pemigatinib for advanced pancreatic cancer with FGFR changes
This trial tests a targeted pill, pemigatinib, for people with advanced pancreatic cancer that has a specific FGFR gene change. The study is done entirely through telemedicine, so you can participate from home if eligible.
Birmingham, AlabamaAges 18 years+ - NCT06912828Recruiting
Genes and diet for IBS
This trial is studying whether your genes can predict how well a special diet will help your IBS symptoms. If you have moderate to severe IBS and no other diet-related conditions, you may be able to take part.
AthensAges 18–65 - NCT06917690RecruitingPhase 3
Testing oleogel-S10 for epidermolysis bullosa in Japanese patients
This trial tests a gel called oleogel-S10 on wounds caused by a rare skin condition called epidermolysis bullosa (EB). It is only for people of Japanese descent who have a specific type of EB called junctional or dystrophic EB. The gel is put on the wound to help it heal.
FukuokaAges 3 weeks+ - NCT06927947Recruiting
Helping families learn about inherited cancer risk
This study tests different ways to help family members of people with inherited cancer syndromes get genetic testing. It aims to improve cancer prevention and early detection.
Ann Arbor, MichiganAges 18 years+ - NCT06935253Recruiting
AI to Improve Cardiology Care
This trial tests whether large language models (a type of AI that understands human language) can help cardiologists give better care. If you are a qualified cardiologist who currently treats patients, you may be eligible.
Palo Alto, CaliforniaAges 18 years+ - NCT06937853Recruiting
Genes and painkiller response for tooth pain
This trial tests whether your genes affect how well a common painkiller (NSAID) works for tooth pain after a root canal procedure. It may help find the best pain relief for you.
Erzurum, ErzurumAges 18–65 - NCT06938867RecruitingPhase 1/Phase 2
Study of SNIPR001 for resistant gut bacteria before stem cell transplant
This study tests an experimental oral medicine called SNIPR001. It is designed to reduce resistant E. coli bacteria in the gut before your stem cell transplant, possibly lowering the risk of infection.
Duarte, CaliforniaAges 18 years+ - NCT06944067Recruiting
Genetic risk of immune response after blood transfusions in sickle cell disease
This study looks at whether certain genes make people with sickle cell disease more likely to develop an immune reaction to blood transfusions. It aims to help doctors predict transfusion risks and improve care.
Bethesda, MarylandAges 2–99 - NCT06952413RecruitingPhase 2
Rituximab for chronic fatigue syndrome (ME/CFS) trial
This trial tests if rituximab, a drug that affects the immune system, can help people with ME/CFS. You'll receive the drug in the hospital and be monitored for safety and improvement.
Kodaira, TokyoAges 18–65 - NCT06953180Recruiting
Epigenetics, aging, and disease prevention study in Kazakhstan
This study looks at how your genes and environment affect your risk for non-communicable diseases like heart disease or diabetes. It aims to predict your biological age and help create personalized prevention plans.
Almaty, KazakhstanAges 18–69 - NCT06962059Recruiting
Healthy volunteers with ovaries needed for study
This study is looking for healthy volunteers who still have their ovaries and have not had cancer or certain genetic mutations. Researchers want to learn more about ovarian health.
Philadelphia, PennsylvaniaAges 30–50 - NCT06975241RecruitingPhase 4
How your body processes EPA from fish oil
This study looks at how your genes and sex affect the way your body uses EPA, a key fat found in fish oil. If you are healthy and not currently eating fish or taking fish oil supplements, you may help researchers learn why people respond differently to omega-3s.
Toronto, OntarioAges 18–35 - NCT06991114RecruitingPhase 2
AlloNK and rituximab for relapsing rheumatologic diseases
This trial tests a new natural killer (NK) cell therapy called AlloNK given with rituximab for people with certain autoimmune diseases (rheumatoid arthritis, Sjögren's disease, inflammatory myopathies, or systemic sclerosis) that have not responded well to standard treatments. The goal is to see if this combination can better control the disease.
Tuscaloosa, AlabamaAges 18 years+
Hear when a new Genetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for genetics?
- Yes. Clin2 currently lists 704 recruiting genetics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a genetics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a genetics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.